Reaction: Sertraline to 1 product
- Reaction
- Reaction type
- N-demethylation
- Direction
- Not Available
- Major circulating metabolite?
- No
- Spontaneous?
- No
- Activity
- unknown
- References
- Fishback JA, Robson MJ, Xu YT, Matsumoto RR: Sigma receptors: potential targets for a new class of antidepressant drug. Pharmacol Ther. 2010 Sep;127(3):271-82. doi: 10.1016/j.pharmthera.2010.04.003. Epub 2010 May 11. [Article]
- Sproule BA, Otton SV, Cheung SW, Zhong XH, Romach MK, Sellers EM: CYP2D6 inhibition in patients treated with sertraline. J Clin Psychopharmacol. 1997 Apr;17(2):102-6. doi: 10.1097/00004714-199704000-00007. [Article]
- Obach RS, Cox LM, Tremaine LM: Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study. Drug Metab Dispos. 2005 Feb;33(2):262-70. Epub 2004 Nov 16. [Article]
- FDA Approved Drug Products: Zoloft (sertraline hydrochloride) for oral use [Link]
- Sertraline pathway [Link]
- Comments
- Not Available
- Enzymes
Enzyme Km Vmax Role Cytochrome P450 3A4 Not Available Not Available confirmed Cytochrome P450 2D6 Not Available Not Available confirmed Cytochrome P450 2C9 Not Available Not Available confirmed Cytochrome P450 2C19 Not Available Not Available confirmed Cytochrome P450 2B6 Not Available Not Available confirmed